Humana
About: Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Employees: 67,600
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
17% more call options, than puts
Call options by funds: $2.1B | Put options by funds: $1.8B
2.4% less ownership
Funds ownership: 97.59% [Q2] → 95.19% (-2.4%) [Q3]
5% less funds holding
Funds holding: 961 [Q2] → 917 (-44) [Q3]
16% less repeat investments, than reductions
Existing positions increased: 315 | Existing positions reduced: 376
18% less capital invested
Capital invested by funds: $43.9B [Q2] → $36B (-$7.96B) [Q3]
23% less first-time investments, than exits
New positions opened: 95 | Existing positions closed: 123
44% less funds holding in top 10
Funds holding in top 10: 25 [Q2] → 14 (-11) [Q3]
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
7 analyst ratings
Piper Sandler Jessica Tassan 25% 1-year accuracy 5 / 20 met price target | 1%upside $288 | Neutral Maintained | 15 Jan 2025 |
Truist Securities David Macdonald 57% 1-year accuracy 55 / 96 met price target | 2%upside $290 | Hold Maintained | 6 Jan 2025 |
Morgan Stanley Erin Wright 43% 1-year accuracy 10 / 23 met price target | 6%upside $301 | Equal-Weight Maintained | 17 Dec 2024 |
B of A Securities Kevin Fischbeck 50% 1-year accuracy 12 / 24 met price target | 8%upside $308 | Neutral Upgraded | 6 Nov 2024 |
TD Cowen Gary Taylor 21% 1-year accuracy 4 / 19 met price target | 6%downside $268 | Hold Maintained | 4 Nov 2024 |
Financial journalist opinion
Based on 13 articles about HUM published over the past 30 days
